AAPL   112.54 (+1.21%)
MSFT   203.70 (+0.50%)
FB   276.66 (+3.36%)
GOOGL   1,519.05 (+0.55%)
AMZN   3,198.50 (+1.13%)
TSLA   409.29 (+0.81%)
NVDA   510.31 (+1.04%)
MU   49.70 (-0.60%)
AMD   76.58 (+0.24%)
T   26.59 (+0.34%)
ACB   3.90 (+1.83%)
GILD   57.95 (-1.31%)
NFLX   488.00 (+0.36%)
BA   148.65 (+0.34%)
AAPL   112.54 (+1.21%)
MSFT   203.70 (+0.50%)
FB   276.66 (+3.36%)
GOOGL   1,519.05 (+0.55%)
AMZN   3,198.50 (+1.13%)
TSLA   409.29 (+0.81%)
NVDA   510.31 (+1.04%)
MU   49.70 (-0.60%)
AMD   76.58 (+0.24%)
T   26.59 (+0.34%)
ACB   3.90 (+1.83%)
GILD   57.95 (-1.31%)
NFLX   488.00 (+0.36%)
BA   148.65 (+0.34%)
AAPL   112.54 (+1.21%)
MSFT   203.70 (+0.50%)
FB   276.66 (+3.36%)
GOOGL   1,519.05 (+0.55%)
AMZN   3,198.50 (+1.13%)
TSLA   409.29 (+0.81%)
NVDA   510.31 (+1.04%)
MU   49.70 (-0.60%)
AMD   76.58 (+0.24%)
T   26.59 (+0.34%)
ACB   3.90 (+1.83%)
GILD   57.95 (-1.31%)
NFLX   488.00 (+0.36%)
BA   148.65 (+0.34%)
AAPL   112.54 (+1.21%)
MSFT   203.70 (+0.50%)
FB   276.66 (+3.36%)
GOOGL   1,519.05 (+0.55%)
AMZN   3,198.50 (+1.13%)
TSLA   409.29 (+0.81%)
NVDA   510.31 (+1.04%)
MU   49.70 (-0.60%)
AMD   76.58 (+0.24%)
T   26.59 (+0.34%)
ACB   3.90 (+1.83%)
GILD   57.95 (-1.31%)
NFLX   488.00 (+0.36%)
BA   148.65 (+0.34%)
Log in
OTCMKTS:VRSEF

Verisante Technology Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume45,260 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta1.61
Verisante Technology Inc., a medical device company, engages in commercializing skin cancer detection systems. The company's products comprise Verisante Aura, which helps in the detection of various forms of skin cancer, including basal cell and squamous cell carcinoma, and melanoma; and Verisante Core for the detection of lung, cervical, gastrointestinal, and colo-rectal cancers. It also owns all the rights to the ClearVu and ClearVu Elite endoscopy systems for the detection of lung cancer. Verisante Technology has a licensing agreement with the BC Cancer Agency for the manufacture, distribution, and sale of products based on patented skin cancer detection technology. The company was formerly known as T-Ray Science Inc. and changed its name to Verisante Technology Inc. in January 2011. Verisante Technology Inc. was founded in 2006 and is based in Richmond, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.48 out of 5 stars

Industry, Sector and Symbol

Industry Health services
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:VRSEF
CUSIPN/A
CIKN/A
Phone604-605-0507
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable
30 days | 90 days | 365 days | Advanced Chart

Receive VRSEF News and Ratings via Email

Sign-up to receive the latest news and ratings for VRSEF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Verisante Technology (OTCMKTS:VRSEF) Frequently Asked Questions

Who are some of Verisante Technology's key competitors?

Who are Verisante Technology's key executives?

Verisante Technology's management team includes the following people:
  • Mr. Thomas A. Braun BA, J.D., LLM, Pres, CEO & Director (Age 51)
  • Mr. Zi Cheng Xu, CFO & Director
  • Mr. Rizah Bahic, Exec. Officer

What is Verisante Technology's stock symbol?

Verisante Technology trades on the OTCMKTS under the ticker symbol "VRSEF."

How do I buy shares of Verisante Technology?

Shares of VRSEF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Verisante Technology's official website?

The official website for Verisante Technology is www.verisante.com.

How can I contact Verisante Technology?

Verisante Technology's mailing address is 2639 Viking Way Suite 140, Richmond A1, V6V 3B7. The company can be reached via phone at 604-605-0507.

This page was last updated on 10/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.